BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 28828692)

  • 1. Systemic Inflammation Response Index (SIRI), cancer stem cells and survival of localised gastric adenocarcinoma after curative resection.
    Li S; Lan X; Gao H; Li Z; Chen L; Wang W; Song S; Wang Y; Li C; Zhang H; Xue Y
    J Cancer Res Clin Oncol; 2017 Dec; 143(12):2455-2468. PubMed ID: 28828692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy.
    Qi Q; Zhuang L; Shen Y; Geng Y; Yu S; Chen H; Liu L; Meng Z; Wang P; Chen Z
    Cancer; 2016 Jul; 122(14):2158-67. PubMed ID: 27152949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment Neutrophil to Lymphocyte Ratio Independently Predicts Disease-specific Survival in Resectable Gastroesophageal Junction and Gastric Adenocarcinoma.
    Wang SC; Chou JF; Strong VE; Brennan MF; Capanu M; Coit DG
    Ann Surg; 2016 Feb; 263(2):292-7. PubMed ID: 25915915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic importance of RASSF2 expression in patients with gastric cancer who had undergone radical gastrectomy.
    Aydin D; Bilici A; Kayahan S; Yavuzer D; Basar M; Aliustaoglu M
    Clin Transl Oncol; 2016 Jun; 18(6):608-16. PubMed ID: 26459248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The systemic inflammation response index predicts survival and recurrence in patients with resectable pancreatic ductal adenocarcinoma.
    Li S; Xu H; Wang W; Gao H; Li H; Zhang S; Xu J; Zhang W; Xu S; Li T; Ni Q; Yu X; Wu C; Liu L
    Cancer Manag Res; 2019; 11():3327-3337. PubMed ID: 31114368
    [No Abstract]   [Full Text] [Related]  

  • 6. Postoperative complications do not impact on recurrence and survival after curative resection of gastric cancer.
    Climent M; Hidalgo N; Vidal Ó; Puig S; Iglesias M; Cuatrecasas M; Ramón JM; García-Albéniz X; Grande L; Pera M
    Eur J Surg Oncol; 2016 Jan; 42(1):132-9. PubMed ID: 26385054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of CD44-positive cancer stem-like cells at the invasive front of gastric cancer.
    Kodama H; Murata S; Ishida M; Yamamoto H; Yamaguchi T; Kaida S; Miyake T; Takebayashi K; Kushima R; Tani M
    Br J Cancer; 2017 Jan; 116(2):186-194. PubMed ID: 27931044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic immune-inflammation index, thymidine phosphorylase and survival of localized gastric cancer patients after curative resection.
    Huang L; Liu S; Lei Y; Wang K; Xu M; Chen Y; Liu B; Chen Y; Fu Q; Zhang P; Qin K; Cai Y; Fu S; Ge S; Yuan X
    Oncotarget; 2016 Jul; 7(28):44185-44193. PubMed ID: 27283904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absolute monocyte and lymphocyte count prognostic score for patients with gastric cancer.
    Eo WK; Jeong DW; Chang HJ; Won KY; Choi SI; Kim SH; Chun SW; Oh YL; Lee TH; Kim YO; Kim KH; Ji YI; Kim A; Kim HY
    World J Gastroenterol; 2015 Mar; 21(9):2668-76. PubMed ID: 25759535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors and outcomes in Italian patients undergoing curative gastric cancer surgery.
    Posteraro B; Persiani R; Dall'Armi V; Biondi A; Arzani D; Sicoli F; Bonassi S; D'Ugo D; Ricciardi W; Boccia S
    Eur J Surg Oncol; 2014 Mar; 40(3):345-51. PubMed ID: 24268760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting recurrence after curative resection for gastric cancer: External validation of the Italian Research Group for Gastric Cancer (GIRCG) prognostic scoring system.
    Barchi LC; Yagi OK; Jacob CE; Mucerino DR; Ribeiro U; Marrelli D; Roviello F; Cecconello I; Zilberstein B
    Eur J Surg Oncol; 2016 Jan; 42(1):123-31. PubMed ID: 26365755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors Associated With Recurrence and Survival in Lymph Node-negative Gastric Adenocarcinoma: A 7-Institution Study of the US Gastric Cancer Collaborative.
    Jin LX; Moses LE; Squires MH; Poultsides GA; Votanopoulos K; Weber SM; Bloomston M; Pawlik TM; Hawkins WG; Linehan DC; Strasberg SM; Schmidt C; Worhunsky DJ; Acher AW; Cardona K; Cho CS; Kooby DA; Levine E; Winslow ER; Saunders ND; Spolverato G; Maithel SK; Fields RC
    Ann Surg; 2015 Dec; 262(6):999-1005. PubMed ID: 25607760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive effect of the systemic inflammation response index (SIRI) on the efficacy and prognosis of neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.
    Ding Y; Liu Z; Li J; Niu W; Li C; Yu B
    BMC Surg; 2024 Mar; 24(1):89. PubMed ID: 38481180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
    Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
    Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy.
    Aydin D; Bilici A; Yavuzer D; Kefeli U; Tan A; Ercelep O; Mert A; Yuksel S; Ozcelik M; Isik D; Surmeli H; Odabasi H; Aliustaoglu M
    Clin Transl Oncol; 2015 Aug; 17(8):604-11. PubMed ID: 25786367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of gastric cancer survival following R0 resection in the United States and Korea using an internationally validated nomogram.
    Strong VE; Song KY; Park CH; Jacks LM; Gonen M; Shah M; Coit DG; Brennan MF
    Ann Surg; 2010 Apr; 251(4):640-6. PubMed ID: 20224369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tobacco use is associated with increased recurrence and death from gastric cancer.
    Smyth EC; Capanu M; Janjigian YY; Kelsen DK; Coit D; Strong VE; Shah MA
    Ann Surg Oncol; 2012 Jul; 19(7):2088-94. PubMed ID: 22395977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Significance of Serum Inflammatory Markers in Gastric Cancer.
    Powell AGMT; Parkinson D; Patel N; Chan D; Christian A; Lewis WG
    J Gastrointest Surg; 2018 Apr; 22(4):595-605. PubMed ID: 29234999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Value of Cyclin D1 and CD44 Expression in Gastric Adenocarcinoma.
    Ibrahim HM; AbdElbary AM; Mohamed SY; Elwan A; Abdelhamid MI; Ibrahim A
    J Gastrointest Cancer; 2019 Sep; 50(3):370-379. PubMed ID: 29497929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
    Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
    Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.